euro adhoc: Intercell AG
Personnel
Realignment in Intercells Supervisory
Board
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement.
29.12.2005
Intercell AG (VSE, "ICLL") today announced that the following persons have resigned as members of the supervisory board of the company:
Emilio A. Emini, who joined Intercells Supervisory Board in January 2005, has taken on new challenges within the vaccine industry and will head vaccine research and development as Executive Vice President at the pharmaceutical company Wyeth.
Cathrin Petty, who represented the private equity firm Apax on Intercells Supervisory Board, resigns from her position.
Therefore, the Supervisory Board of Intercell now consists of the following members: Ernst-Günter Afting (Chairman), David Ebsworth, Luke Evnin, Michel Gréco, Hans Küpper, Helmut Schühsler and James Sulat.
The Board of Directors wish to thank the members of the Supervisory Board who have resigned and who will remain in contact with the company for their long and good cooperation.
This communication expressly or implicitly contains certain forward-looking statements concerning Intercell AG and its business. Such statements involve certain known and unknown risks, uncertainties and other factors which could cause the actual results, financial condition, performance or achievements of Intercell AG to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Intercell AG is providing this communication as of this date and does not undertake to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
end of announcement euro adhoc 29.12.2005 17:45:00
Further inquiry note:
Intercell AG
Mag. Katharina Wieser
Head of Corporate Communications
Tel. +43 1 20620-303
kwieser@intercell.com
Branche: Biotechnology
ISIN: AT0000612601
WKN: A0D8HW
Börsen: Wiener Börse AG / official market